Transcription Factor NFATc2 Controls the Emergence of Colon Cancer Associated with IL-6-Dependent Colitis.


Autoria(s): Gerlach K.; Daniel C.; Lehr H.A.; Nikolaev A.; Gerlach T.; Atreya R.; Rose-John S.; Neurath M.F.; Weigmann B.
Data(s)

2012

Resumo

NFAT transcription factors control T-cell activation and function. Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation. Here, we used an experimental model of colitis-associated colorectal carcinoma to investigate the contribution of NFATc2 to the promotion of colonic tumors. Compared with wild-type animals that readily presented with multiple colon tumors, NFATc2-deficient mice were protected from tumor development. This observed decrease in colonic tumor progression was associated with reduced endoscopic inflammation, increased apoptosis of lamina propria T lymphocytes, and significantly reduced levels of the critical proinflammatory cytokines interleukin (IL)-21 and IL-6. Administration of hyper IL-6 abrogated protection from tumor progression in NFATc2-knockout mice and restored tumor incidence to control levels. Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression. Cancer Res; 72(17); 4340-50. ©2012 AACR.

Identificador

http://serval.unil.ch/?id=serval:BIB_994019979643

isbn:1538-7445 (Electronic)

pmid:22738913

doi:10.1158/0008-5472.CAN-11-4155

isiid:000308565600008

Idioma(s)

en

Fonte

Cancer Research, vol. 72, no. 17, pp. 4340-4350

Tipo

info:eu-repo/semantics/article

article